This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database.
Subcutaneous implantation of estradiol pellets for postmenopausal disorders. Lansdale: HAYES, Inc.. Healthcare Technology Brief Publication. 2010
<p>Menopause, the cessation of menstruation, occurs at around age 50 years for most women. During this process, levels of the hormone estrogen fall dramatically and women may experience hot flashes, sleep disorders, mood swings, vaginal dryness, and decreased sexual desire. In addition, osteoporosis can occur if estrogen levels remain low for prolonged periods. These symptoms can be reduced or prevented by use of hormone replacement therapy (HRT), which typically involves administration of estrogen and progesterone via pills, skin patches, or gels.</p>
This report has been archived and may contain outdated information. To request a copy of the report please contact the organisation directly.
Subject indexing assigned by CRD
Estrogen Replacement Therapy; Estrogens; Females; Postmenopause; Prostheses and Implants; Subcutaneous Tissue
Country of organisation
An English language summary is available.
Address for correspondence
HAYES, Inc., 157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218 Email: email@example.com
Date abstract record published